CLDX EBITDA Margin

Celldex Therapeutics Inc · EBITDA Margin

CLDX logo

CLDX EBITDA Margin

Latest reported-265353.57%
CLDX TTM EBITDA Margin (145.45% → -265353.57%)
High-resolution chart · PNG

CLDX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Celldex Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-265,353.5714%
-34,185.6098%
-17,028%
-8,505.7308%
-3,389.121%
-2,322.8205%
-2,203.5043%
-1,431.245%
-1,673.5606%
-2,200.9223%
-1,892.2272%
-2,787.8121%
-3,388.8786%
-3,414.0635%
-4,322.8681%
-8,894.6197%
-10,709.2233%
-1,779.3045%
-1,420.4643%
-688.387%
-581.6431%
-922.1622%
-615.3971%
-1,054.7024%
-1,082.3971%
-981.6448%
-1,390.0644%
-1,150.4494%
-1,079.6491%
-921.2389%
-761.357%
-751.9505%
-653.5571%
-630.1434%
-816.2678%
-972.0634%
-1,218.3462%
-1,709.2205%
-1,834.9985%
-1,902.5216%
-2,356.9172%
-2,067.3813%
-2,290.6934%
-2,406.8899%
-2,336.8752%
-3,239.2779%
-3,249.5538%
-3,910.1136%
-3,825.0767%
-4,258.1164%
-1,909.4381%
-1,022.2892%
-694.952%
-527.9531%
-487.4933%
-499.3293%
-497.8353%
-462.6116%
-419.2337%
-0.808%
4.3411%
6.6475%
9.9694%
-248.9605%
-213.8783%
-217.954%
-217.8575%
-212.5454%
-253.9969%
-284.8672%
-422.0055%
-468.5957%
-602.8398%
-539.4278%
-333.5371%
-553.064%
-612.8262%
-908.2245%
-411.0979%
-337.4321%
-280.7482%
-248.3487%
-541.8883%
-337.8868%
-346.4911%
-312.6385%
-173.0132%
-211.226%
-140.2195%
-124.4898%
-220.1472%
-233.3842%
-126.0065%
-166.8399%
-191.0498%
-236.3173%
-740.5556%
-718.7293%
-666.59%
-759.9948%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.